NEW YORK (GenomeWeb) – Mbio Diagnostics today announced a product development and licensing agreement with Roka Bioscience.
The partnership will join MBio's multiplex, point-of-care diagnostics technology with Roka's solutions for food safety testing. The agreement covers "certain exclusive and non-exclusive fields," the firms said in a statement. Boulder, Colorado-based MBio and Warren, New Jersey-based Roka said they will jointly carry out product development.
Financial and other terms of the agreement were not disclosed.